Phospholipase A/
acyltransferase (PLA/AT)-3 (also known as H-rev107 or AdPLA) was originally isolated as a
tumor suppressor and was later shown to have
phospholipase A1/A2 activity. We have also found that the overexpression of PLA/AT-3 in mammalian cells results in specific disappearance of peroxisomes. However, its molecular mechanism remained unclear. In the present study, we first established a HEK293 cell line, which stably expresses a fluorescent peroxisome marker
protein (DsRed2-Peroxi) and expresses PLA/AT-3 in a
tetracycline-dependent manner. The treatment with
tetracycline, as expected, caused disappearance of peroxisomes within 24 h, as revealed by diffuse signals of DsRed2-Peroxi and a remarkable decrease in a peroxisomal
membrane protein, PMP70. A time-dependent decrease in
ether-type
lipid levels was also seen. Because the activation of LC3, a marker of autophagy, was not observed, the involvement of autophagy was unlikely. Among various
peroxins responsible for peroxisome biogenesis, Pex19p functions as a chaperone
protein for the transportation of peroxisomal
membrane proteins. Immunoprecipitation analysis showed that PLA/AT-3 binds to Pex19p through its N-terminal
proline-rich and C-terminal hydrophobic domains. The
protein level and
enzyme activity of PLA/AT-3 were increased by its coexpression with Pex19p. Moreover, PLA/AT-3 inhibited the binding of Pex19 to peroxisomal
membrane proteins, such as Pex3p and Pex11βp. A catalytically inactive point mutant of PLA/AT-3 could bind to Pex19p but did not inhibit the chaperone activity of Pex19p. Altogether, these results suggest a novel regulatory mechanism for peroxisome biogenesis through the interaction between Pex19p and PLA/AT-3.